Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rapp

Showing results (31-40 of 319) with videos related to

Pageof 32
Sort By:
Pharmacotherapy|August 24, 1999
Antimicrobial resistance in gram-positive bacteria: the myth of the MIC. Minimum inhibitory concentrationR P Rapp
Drug Intelligence & Clinical Pharmacy|February 12, 1975
"Pharmacists' Syndrome"R P Rapp
Surgical Infections|February 22, 2003
Overview of resistant gram-positive pathogens in the surgical patientR P Rapp
The Annals of Pharmacotherapy|July 1, 1992
Temafloxacin voluntary withdrawal: concerns about multicenter testing and postmarketing surveillanceR P Rapp
The Annals of Pharmacotherapy|May 17, 2007
A perspective on 45 years in clinical pharmacy educationRobert P Rapp
Drug Intelligence & Clinical Pharmacy|October 1, 1987
Comment: cefoperazone therapy economicsR P Rapp
Drug Intelligence & Clinical Pharmacy|June 1, 1987
Premixed and frozen admixtures: extending the time of drug exclusivityR P Rapp
Hypertension (Dallas, Tex. : 1979)|July 1, 1987
Use and misuse of control strains for genetically hypertensive ratsJ P Rapp
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 19, 2003
Standardized residency trainingRobert P Rapp
The Annals of Pharmacotherapy|January 5, 2006
Pharmacy infectious diseases practiceRobert P Rapp
Pageof 32

Showing results (31-40 of 319) with videos related to

Sort By:
Pageof 32
Pharmacotherapy|August 24, 1999
Antimicrobial resistance in gram-positive bacteria: the myth of the MIC. Minimum inhibitory concentrationR P Rapp
Drug Intelligence & Clinical Pharmacy|February 12, 1975
"Pharmacists' Syndrome"R P Rapp
Surgical Infections|February 22, 2003
Overview of resistant gram-positive pathogens in the surgical patientR P Rapp
The Annals of Pharmacotherapy|July 1, 1992
Temafloxacin voluntary withdrawal: concerns about multicenter testing and postmarketing surveillanceR P Rapp
The Annals of Pharmacotherapy|May 17, 2007
A perspective on 45 years in clinical pharmacy educationRobert P Rapp
Drug Intelligence & Clinical Pharmacy|October 1, 1987
Comment: cefoperazone therapy economicsR P Rapp
Drug Intelligence & Clinical Pharmacy|June 1, 1987
Premixed and frozen admixtures: extending the time of drug exclusivityR P Rapp
Hypertension (Dallas, Tex. : 1979)|July 1, 1987
Use and misuse of control strains for genetically hypertensive ratsJ P Rapp
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 19, 2003
Standardized residency trainingRobert P Rapp
The Annals of Pharmacotherapy|January 5, 2006
Pharmacy infectious diseases practiceRobert P Rapp
Pageof 32